Meningococcal vaccine groups B C - Chiron/NIPH
Latest Information Update: 15 Aug 2007
At a glance
- Originator Chiron Corporation; Nonindustrial source
- Developer Chiron Corporation
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Meningococcal group B infections; Meningococcal group C infections
Most Recent Events
- 16 Nov 1999 New profile
- 16 Nov 1999 Preclinical development for Meningococcal group B infections in USA (Unknown route)
- 16 Nov 1999 Preclinical development for Meningococcal group C infections in USA (Unknown route)